+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID06966206

Study of Multiprofen-CC Cream to Ease Pain and Improve Function in Adults with Hand Osteoarthritis A Phase 3 Randomized Crossover Trial Comparing Active Cream to Placebo

Led by St. Joseph's Healthcare Hamilton · Updated on 2026-05-04

42

Participants Needed

1

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether applying 1 gram of Multiprofen-CC cream to the hands three times daily for 4 weeks can reduce pain in adults with hand osteoarthritis, compared to a placebo cream without active medicine. This Phase 3 clinical trial also examines how this treatment affects hand function, opioid use, and patients overall improvement while monitoring any side effects. Participants will use both the active Multiprofen-CC cream and a placebo cream in a random order, applying each 1 gram dose three times daily for 2 weeks. The cream contains ketoprofen, baclofen, amitriptyline, and lidocaine, while the placebo cream contains no medicinal ingredients. The study includes a crossover design where participants switch between treatments. During the study, participants will attend visits before starting, after 2 weeks, and again after 6 weeks. They will report symptoms and side effects throughout. Researchers will measure pain intensity at baseline, weeks 2, 4, and 6, along with hand function and patient-reported improvement. Safety is monitored by tracking adverse events over approximately 6 weeks.

CONDITIONS

Brief Title

Multiprofen-CC to Reduce Pain in Hand Arthritis

Research Team

B

Breanne Flood, MSc

K

Kim Irish, BSW

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here